vimarsana.com

Page 17 - பல்கலைக்கழகம் ஆஃப் உட்டா பள்ளி மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Patients with traumatic brain injuries face challenges navigating healthcare system

 E-Mail IMAGE: Many traumatic brain injury (TBI) survivors needed extensive healthcare services in the year after their injury, and a quarter of them were super-utilizers, having three or more emergency department visits. view more  Credit: Regenstrief Institute INDIANAPOLIS Patients who suffer from traumatic brain injuries (TBI) often need a great deal of healthcare services after the injury, but the extent of care utilization is unknown. A new study from research scientists affiliated with the U.S. Department of Veterans Affairs (VA), Regenstrief Institute and IUPUI is one of the first to analyze how much care TBI patients use and identify areas of unmet need.

Targeting brain protein may lead to new therapeutic approaches for neurodegenerative disorders

Targeting brain protein may lead to new therapeutic approaches for neurodegenerative disorders Neurological disorders are the number one cause of disability in the world, leading to seven million deaths each year. Yet few treatments exist for these diseases, which progressively diminish a person s ability to move and think. Now, a new study suggests that some of these neurological disorders share a common underlying thread. Staufen1, a protein that accumulates in the brains of patients with certain neurological conditions, is linked to amyotrophic lateral sclerosis (ALS), or Lou Gehrig s disease, along with other neurological disorders, including Alzheimer s, Parkinson s, and Huntington s disease, according to University of Utah Health scientists.

No, your blood type doesn t affect risk of COVID-19 or severe illness, new Utah study finds

KSL TV SALT LAKE CITY Your blood type does not factor in your risk for contracting COVID-19 or developing a severe case of it, researchers at Intermountain Healthcare and other institutions determined. Their findings, published in the Journal of American Medical Association earlier this month, counters previous global studies and research that suggested blood type was one factor for why some people suffered symptoms of COVID-19 more than others. I think it s important because it s been, for us, really one of our primary objectives to identify patients who are at higher risk and to build risk scores, said Dr. Jeffrey Anderson, a cardiologist and researcher with the Intermountain Medical Center Heart Institute, and the study s lead researcher.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.